Amgen

Amgen is a global biotechnology company founded in 1980 by Stan O'Connell. The organization has been expanding its operations globally, including recent plans to establish offices in Hong Kong. This expansion highlights Amgen's growing presence in the pharmaceutical industry. In addition, Amgen has been focusing on cardiovascular disease prevention, particularly for women, due to its high mortality rate. Recent news articles have highlighted the company's efforts to raise awareness about this critical issue and promote preventive measures. As a leading biotech firm, Amgen's involvement in addressing this significant health concern underscores its commitment to improving human lives through innovative treatments and research.